We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2368:TWSENBT Inc. Analysis

Data as of 2026-05-31 - not real-time

₩1,363.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NBT Inc. is trading at 1,363 KRW, well below its 20‑day SMA of 1,682, 50‑day SMA of 1,810 and 200‑day SMA of 2,395, indicating a prolonged bearish price trajectory. The 14‑day RSI sits at 21.8, suggesting the stock is technically oversold, yet the MACD histogram remains negative and the signal line is bearish, reinforcing downside momentum. Volatility is elevated at roughly 48% over the past 30 days, while the beta of 0.57 points to lower systematic risk relative to the broader market. Fundamentally, the company reports negative operating (‑7.1%) and profit margins (‑4.1%), a substantial debt‑to‑equity ratio of 21.5, and persistent cash outflows, undermining earnings sustainability. Despite these challenges, the price‑to‑sales multiple is only 0.24, hinting at a potentially undervalued valuation relative to revenue. However, the market sentiment is extremely bullish (Fear‑Greed Index 94.07), creating a dissonance between price enthusiasm and deteriorating fundamentals.
Given the confluence of technical weakness, high volatility, and weak fundamentals, the stock faces significant downside risk. The absence of dividend payments eliminates any income cushion, and the lack of analyst coverage further obscures forward guidance. While the low price‑to‑sales ratio could be seen as a value opportunity, the company’s negative cash generation and high leverage suggest that any recovery would require a substantive operational turnaround.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and negative histogram
  • Elevated short‑term volatility

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Persistently negative operating and profit margins
  • High debt‑to‑equity ratio
  • Lack of cash flow generation

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Structural earnings weakness
  • No dividend or earnings recovery outlook
  • Potential need for strategic restructuring

Key Metrics & Analysis

Financial Health

Revenue Growth0.10%
Profit Margin-4.09%
ROE-17.83%
ROA-7.54%
Debt/Equity21.50
Op. Cash Flow₩-7893885440
Free Cash Flow₩-6002453504
Industry P/E41.9

Technical Analysis

TrendBearish
RSI21.8
Support₩1,350.00
Resistance₩2,050.00
MA 20₩1,682.25
MA 50₩1,810.36
MA 200₩2,395.02
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.57
Volatility47.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.